The Venture Codex Logo

The Venture Codex

TCGX

245 Lytton Ave., Suite 350, Palo Alto, CA, 94301, United States

Overview

Healthcare investment firm advancing disruptive medicines for patients.

Founded

2020

Deals ยท 12mo

11

Links

WebsiteLinkedIn

Stage focus

Series B
Series C

Geographic focus

China
Denmark
Switzerland
United Kingdom
...

Sector focus

Alternative Medicine
Financial Services
Health Care
Life Science
...

Investment portfolio

38rounds
NAMEDATESIZE
Vaderis Therapeutics
Aug 2026Led
$152 MSeries B
Ollin Biosciences
Jun 2026Led
$330 MSeries B
Mentari Therapeutics
May 2026Participated
$290 MOther Equity
Accro Bioscience
May 2026Participated
$50 MSeries C
ADCendo
Apr 2026Participated
$76 MSeries C
Candid Therapeutics
Mar 2026Participated
$505 MOther Equity
Korsana Biosciences
Feb 2026Led
$150 MSeries A
Jixing Pharmaceuticals
Jan 2026Participated
$287 MSeries D
Mirador Therapeutics
Jan 2026Participated
$250 MSeries B
Century Therapeutics
Jan 2026Led
$135 MOther Equity
ADC Therapeutics
Oct 2025Led
$60 MOther Equity
Aviceda Therapeutics
Jan 2025Led
$208 MSeries C
Vaderis Therapeutics
Aug 2026Led
$152 MSeries B
Ollin Biosciences
Jun 2026Led
$330 MSeries B
Mentari Therapeutics
May 2026Participated
$290 MOther Equity
Accro Bioscience
May 2026Participated
$50 MSeries C
ADCendo
Apr 2026Participated
$76 MSeries C
Candid Therapeutics
Mar 2026Participated
$505 MOther Equity
Korsana Biosciences
Feb 2026Led
$150 MSeries A
Jixing Pharmaceuticals
Jan 2026Participated
$287 MSeries D
Mirador Therapeutics
Jan 2026Participated
$250 MSeries B
Century Therapeutics
Jan 2026Led
$135 MOther Equity
ADC Therapeutics
Oct 2025Led
$60 MOther Equity
Aviceda Therapeutics
Jan 2025Led
$208 MSeries C
38
Items
...
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

TCGX: 38 funding rounds are recorded in the selected participation categories.All available history.
TCGX: 38 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A22
Series B78
Series C+46
Other Equity63

Monthly Deal Activity

TCGX: 38 deals are recorded across 68 months.All available history.
TCGX: 38 deals are recorded across 68 months. All available history
MonthDeals
Mar '212
Apr '210
May '211
Jun '212
Jul '212
Aug '210
Sep '210
Oct '211
Nov '211
Dec '210
Jan '220
Feb '221
Mar '220
Apr '220
May '220
Jun '221
Jul '220
Aug '221
Sep '220
Oct '220
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '231
Jun '232
Jul '230
Aug '233
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '241
Apr '241
May '241
Jun '240
Jul '241
Aug '241
Sep '242
Oct '240
Nov '241
Dec '240
Jan '251
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '251
Nov '250
Dec '250
Jan '263
Feb '261
Mar '261
Apr '261
May '262
Jun '261
Jul '260
Aug '261
Sep '260
Oct '260

Sector Breakdown

TCGX: Health & Life Sciences is the largest displayed sector by deal count (37 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

TCGX: Health & Life Sciences is the largest displayed sector by deal count (37 deals). All available history
SectorDeals
Health & Life Sciences37
Consumer & Lifestyle3
Marketing & Advertising1
Space & Frontier Tech1

Deal Size Distribution

TCGX: 38 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

TCGX: 38 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M0
$10M-$25M0
$25M-$50M0
$50M-$100M5
$100M-$250M25
$250M-$500M7
$500M-$1B1
$1B+0

Deals By Geography

TCGX: United States has the largest recorded deal count among the displayed regions (27 deals).All available history.

Top 3 of 3 regions; European countries are grouped as Europe.

TCGX: United States has the largest recorded deal count among the displayed regions (27 deals). All available history
RegionDeals
United States27
Europe9
China2
TCGX: 20 co-investors are shown, with Venrock sharing 13 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

TCGX: 20 co-investors are shown, with Venrock sharing 13 recorded deals. All available history
Co-investorShared deals
Venrock13
RA Capital Management12
OrbiMed11
Janus Henderson Investors9
Logos Capital9
Omega Funds7
RTW Investments7
Samsara BioCapital7
Surveyor Capital7
Deep Track Capital6
Invus6
T. Rowe Price Associates6
Wellington Management6
Woodline Partners6
Fairmount5
Foresite Capital5
Perceptive Advisors5
Redmile Group5
Soleus Capital5
Vivo Capital5

Investment Strategy

TCGX: Led accounts for 50% and participating for 50% of round participation.All available history.
TCGX: Led accounts for 50% and participating for 50% of round participation. All available history
CategoryDeals (count)Share (%)
Led1950%
Participating1950%
TCGX: Single-lead accounts for 32% and co-led for 68% of lead dynamics.All available history.
TCGX: Single-lead accounts for 32% and co-led for 68% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead632%
Co-led1368%

Team

Cariad Chester

Partner

Chen Yu

Founder & Managing Partner

Giuliano Marostica

Partner